35 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07050 | Temporin-PKE | FLPLIIGALSSLLPKIF | skin secretion of Pelophylax kl. esculentus | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 23.24 μM |
| dbacp07051 | Temporin-PKE | FLPLIIGALSSLLPKIF | skin secretion of Pelophylax kl. esculentus | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 7.29 μM |
| dbacp07052 | Temporin-PKE | FLPLIIGALSSLLPKIF | skin secretion of Pelophylax kl. esculentus | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 16.38 μM |
| dbacp07053 | Temporin-PKE | FLPLIIGALSSLLPKIF | skin secretion of Pelophylax kl. esculentus | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 21.31 μM |
| dbacp07054 | Temporin-PKE | FLPLIIGALSSLLPKIF | skin secretion of Pelophylax kl. esculentus | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 17.40 μM |
| dbacp07055 | Temporin-PKE-2K | FLPLIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 2.49 μM |
| dbacp07056 | Temporin-PKE-2K | FLPLIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 2.64 μM |
| dbacp07057 | Temporin-PKE-2K | FLPLIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 3.07 μM |
| dbacp07058 | Temporin-PKE-2K | FLPLIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 2.84 μM |
| dbacp07059 | Temporin-PKE-2K | FLPLIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 2.78 μM |
| dbacp07060 | Temporin-PKE-K12 | FLPLIIGALSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 25.75 μM |
| dbacp07061 | Temporin-PKE-K12 | FLPLIIGALSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 27.32 μM |
| dbacp07062 | Temporin-PKE-K12 | FLPLIIGALSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 22.67 μM |
| dbacp07063 | Temporin-PKE-K12 | FLPLIIGALSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 22.09 μM |
| dbacp07064 | Temporin-PKE-K12 | FLPLIIGALSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 24.03 μM |
| dbacp07065 | Temporin-PKE-3K | FLPKIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 2.83 μM |
| dbacp07066 | Temporin-PKE-3K | FLPKIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 3.01 μM |
| dbacp07067 | Temporin-PKE-3K | FLPKIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 0.51 μM |
| dbacp07068 | Temporin-PKE-3K | FLPKIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 0.38 μM |
| dbacp07069 | Temporin-PKE-3K | FLPKIIGKLSSLLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 3.29 μM |
| dbacp07070 | Temporin-PKE-4K | FLPKIIGKLSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 85.52 μM |
| dbacp07071 | Temporin-PKE-4K | FLPKIIGKLSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 49.50 μM |
| dbacp07072 | Temporin-PKE-4K | FLPKIIGKLSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 35.28 μM |
| dbacp07073 | Temporin-PKE-4K | FLPKIIGKLSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 99.36 μM |
| dbacp07074 | Temporin-PKE-4K | FLPKIIGKLSSKLPKIF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 27.76 μM |
| dbacp07075 | Temporin-PKE-i | FLPLIIGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 4.46 μM |
| dbacp07076 | Temporin-PKE-i | FLPLIIGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 3.35 μM |
| dbacp07077 | Temporin-PKE-i | FLPLIIGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 5.28 μM |
| dbacp07078 | Temporin-PKE-i | FLPLIIGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 3.07 μM |
| dbacp07079 | Temporin-PKE-i | FLPLIIGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 2.94 μM |
| dbacp07080 | Temporin-PKE-3i | FLPLiiGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | U251-MG | Brain Tumor | IC50 = 120.6 μM |
| dbacp07081 | Temporin-PKE-3i | FLPLiiGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | PC-3 | Prostate Cancer | IC50 = 167 μM |
| dbacp07082 | Temporin-PKE-3i | FLPLiiGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-838 | Lung Cancer | IC50 = 193.4 μM |
| dbacp07083 | Temporin-PKE-3i | FLPLiiGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | HCT-116 | Colorectal Cancer | IC50 = 72.06 μM |
| dbacp07084 | Temporin-PKE-3i | FLPLiiGALSSLLPKiF | Synthetic | Charge-optimized membranolysis induces apoptosis. | MTT assay | H-157 | Lung Cancer | IC50 = 71.18 μM |